Cabozantinib,Nivolumab,Ipilimumab
BMS
['nivo', 'ipilimumab', '/ipi', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'nivolumab']
dr. bradley mcgregor discusses cabozantinib/nivolumab/ipilimumab in advanced rcc with variant histologies. #urology #urologist #kidneycancer #asco23 
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.